BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26944438)

  • 1. SphK1 inhibitor SKI II inhibits the proliferation of human hepatoma HepG2 cells via the Wnt5A/β-catenin signaling pathway.
    Liu H; Zhang CX; Ma Y; He HW; Wang JP; Shao RG
    Life Sci; 2016 Apr; 151():23-29. PubMed ID: 26944438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus X protein promotes human hepatoma cell growth via upregulation of transcription factor AP2α and sphingosine kinase 1.
    Lu ZP; Xiao ZL; Yang Z; Li J; Feng GX; Chen FQ; Li YH; Feng JY; Gao YE; Ye LH; Zhang XD
    Acta Pharmacol Sin; 2015 Oct; 36(10):1228-36. PubMed ID: 26073327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The blockage of Ras/ERK pathway augments the sensitivity of SphK1 inhibitor SKI II in human hepatoma HepG2 cells.
    Zhang C; He H; Zhang H; Yu D; Zhao W; Chen Y; Shao R
    Biochem Biophys Res Commun; 2013 Apr; 434(1):35-41. PubMed ID: 23545258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paeoniflorin Affects Hepatocellular Carcinoma Progression by Inhibiting Wnt/β-Catenin Pathway through Downregulation of 5-HT1D.
    Zhou Y; Liu X; Gao Y; Tan R; Wu Z; Zhong Q; Zeng F
    Curr Pharm Biotechnol; 2021; 22(9):1246-1253. PubMed ID: 33038910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Klotho suppresses liver cancer progression and induces cell apoptosis by negatively regulating wnt/β-catenin signaling pathway.
    Sun H; Gao Y; Lu K; Zhao G; Li X; Li Z; Chang H
    World J Surg Oncol; 2015 Oct; 13():307. PubMed ID: 26499380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibitions of SphK1 inhibitor SKI II on cell cycle progression and cell invasion of hepatoma HepG2 cells].
    Zhang CX; Liu H; Gong YY; He HW; Shao RG
    Yao Xue Xue Bao; 2014 Feb; 49(2):204-8. PubMed ID: 24761610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct roles and differential expression levels of Wnt5a mRNA isoforms in colorectal cancer cells.
    Huang TC; Lee PT; Wu MH; Huang CC; Ko CY; Lee YC; Lin DY; Cheng YW; Lee KH
    PLoS One; 2017; 12(8):e0181034. PubMed ID: 28859077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FH535 inhibits the proliferation of HepG2 cells via downregulation of the Wnt/β-catenin signaling pathway.
    Liu J; Li G; Liu D; Liu J
    Mol Med Rep; 2014 Apr; 9(4):1289-92. PubMed ID: 24482011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dichlorodiphenyltrichloroethane exposure induces the growth of hepatocellular carcinoma via Wnt/β-catenin pathway.
    Jin XT; Song L; Zhao JY; Li ZY; Zhao MR; Liu WP
    Toxicol Lett; 2014 Feb; 225(1):158-66. PubMed ID: 24355586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirfenidone Inhibits Proliferation and Promotes Apoptosis of Hepatocellular Carcinoma Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway.
    Zou WJ; Huang Z; Jiang TP; Shen YP; Zhao AS; Zhou S; Zhang S
    Med Sci Monit; 2017 Dec; 23():6107-6113. PubMed ID: 29276937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-glucose promotes proliferation of human bladder cancer T24 cells by activating Wnt/β-catenin signaling pathway.
    Gao L; Xu FM; Shi WJ; Zhang S; Lu YL; Zhao DK; Long YF; Teng RB; Ge B
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8151-8160. PubMed ID: 30556853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of trichostatin A on anti HepG2 liver carcinoma cells: inhibition of HDAC activity and activation of Wnt/β-Catenin signaling.
    Shi QQ; Zuo GW; Feng ZQ; Zhao LC; Luo L; You ZM; Li DY; Xia J; Li J; Chen DL
    Asian Pac J Cancer Prev; 2014; 15(18):7849-55. PubMed ID: 25292076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WNT5A inhibits hepatocyte proliferation and concludes β-catenin signaling in liver regeneration.
    Yang J; Cusimano A; Monga JK; Preziosi ME; Pullara F; Calero G; Lang R; Yamaguchi TP; Nejak-Bowen KN; Monga SP
    Am J Pathol; 2015 Aug; 185(8):2194-205. PubMed ID: 26100214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Short hairpin RNA mediated glypican-3 silencing inhibits hepatoma cell invasiveness and disrupts molecular pathways of angiogenesis].
    Yu DD; Yao M; Chen J; Wang L; Yan MJ; Gu X; Qiu LW; Dong ZZ; Yao DF; Lu SL
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):452-8. PubMed ID: 24034848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1118-20, an indazole diarylurea compound, inhibits hepatocellular carcinoma HepG2 proliferation and tumour angiogenesis involving Wnt/β-catenin pathway and receptor tyrosine kinases.
    Lu YY; Wang JJ; Zhang XK; Li WB; Guo XL
    J Pharm Pharmacol; 2015 Oct; 67(10):1393-405. PubMed ID: 26076716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway.
    Xu J; Zhu X; Wu L; Yang R; Yang Z; Wang Q; Wu F
    Liver Int; 2012 May; 32(5):752-60. PubMed ID: 22276989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
    Tang Y; Berlind J; Mavila N
    Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMQ-T-F5 (1-(4-(2-aminoquinazolin-7-yl)phenyl)-3-(2‑bromo‑5- (trifluoromethoxy)phenyl) thiourea) suppress proliferation and migration of human cervical HeLa cells via inhibiting Wnt/β-catenin signaling pathway.
    Dai B; Yang T; Shi X; Ma N; Kang Y; Zhang J; Zhang Y
    Phytomedicine; 2018 Dec; 51():48-57. PubMed ID: 30466627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both glypican-3/Wnt/β-catenin signaling pathway and autophagy contributed to the inhibitory effect of curcumin on hepatocellular carcinoma.
    Hu P; Ke C; Guo X; Ren P; Tong Y; Luo S; He Y; Wei Z; Cheng B; Li R; Luo J; Meng Z
    Dig Liver Dis; 2019 Jan; 51(1):120-126. PubMed ID: 30001951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.